nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—ABCC1—Cyclosporine—focal segmental glomerulosclerosis	0.374	0.487	CbGbCtD
Mitoxantrone—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.25	0.326	CbGbCtD
Mitoxantrone—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0903	0.117	CbGbCtD
Mitoxantrone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0541	0.0703	CbGbCtD
Mitoxantrone—SLC47A2—kidney—focal segmental glomerulosclerosis	0.0109	0.137	CbGeAlD
Mitoxantrone—SLC47A2—cortex of kidney—focal segmental glomerulosclerosis	0.0107	0.134	CbGeAlD
Mitoxantrone—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.00999	0.0659	CcSEcCtD
Mitoxantrone—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.0551	CcSEcCtD
Mitoxantrone—PIM1—nephron tubule—focal segmental glomerulosclerosis	0.00814	0.102	CbGeAlD
Mitoxantrone—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.00723	0.0476	CcSEcCtD
Mitoxantrone—PIM1—kidney—focal segmental glomerulosclerosis	0.00715	0.0898	CbGeAlD
Mitoxantrone—PIM1—cortex of kidney—focal segmental glomerulosclerosis	0.00696	0.0874	CbGeAlD
Mitoxantrone—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.0392	CcSEcCtD
Mitoxantrone—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.0301	CcSEcCtD
Mitoxantrone—Nephropathy toxic—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.029	CcSEcCtD
Mitoxantrone—SLC47A1—nephron tubule—focal segmental glomerulosclerosis	0.00436	0.0547	CbGeAlD
Mitoxantrone—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.0283	CcSEcCtD
Mitoxantrone—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0271	CcSEcCtD
Mitoxantrone—SLC47A1—kidney—focal segmental glomerulosclerosis	0.00383	0.0481	CbGeAlD
Mitoxantrone—SLC47A1—cortex of kidney—focal segmental glomerulosclerosis	0.00373	0.0468	CbGeAlD
Mitoxantrone—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0244	CcSEcCtD
Mitoxantrone—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.0235	CcSEcCtD
Mitoxantrone—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.0216	CcSEcCtD
Mitoxantrone—CYP1B1—nephron tubule—focal segmental glomerulosclerosis	0.0032	0.0401	CbGeAlD
Mitoxantrone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.0189	CcSEcCtD
Mitoxantrone—CYP1B1—kidney—focal segmental glomerulosclerosis	0.00281	0.0353	CbGeAlD
Mitoxantrone—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0184	CcSEcCtD
Mitoxantrone—CYP1B1—cortex of kidney—focal segmental glomerulosclerosis	0.00273	0.0343	CbGeAlD
Mitoxantrone—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.0179	CcSEcCtD
Mitoxantrone—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.017	CcSEcCtD
Mitoxantrone—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0164	CcSEcCtD
Mitoxantrone—ABCC1—cortex of kidney—focal segmental glomerulosclerosis	0.00246	0.0309	CbGeAlD
Mitoxantrone—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0157	CcSEcCtD
Mitoxantrone—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.00238	0.0299	CbGeAlD
Mitoxantrone—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00219	0.0144	CcSEcCtD
Mitoxantrone—CYP2E1—nephron tubule—focal segmental glomerulosclerosis	0.00206	0.0259	CbGeAlD
Mitoxantrone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0125	CcSEcCtD
Mitoxantrone—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0124	CcSEcCtD
Mitoxantrone—CYP2E1—kidney—focal segmental glomerulosclerosis	0.00181	0.0227	CbGeAlD
Mitoxantrone—CYP2E1—cortex of kidney—focal segmental glomerulosclerosis	0.00176	0.0221	CbGeAlD
Mitoxantrone—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.0113	CcSEcCtD
Mitoxantrone—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.011	CcSEcCtD
Mitoxantrone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.0102	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.00971	CcSEcCtD
Mitoxantrone—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00146	0.0183	CbGeAlD
Mitoxantrone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.0095	CcSEcCtD
Mitoxantrone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00945	CcSEcCtD
Mitoxantrone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00942	CcSEcCtD
Mitoxantrone—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00937	CcSEcCtD
Mitoxantrone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00918	CcSEcCtD
Mitoxantrone—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00915	CcSEcCtD
Mitoxantrone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00913	CcSEcCtD
Mitoxantrone—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00908	CcSEcCtD
Mitoxantrone—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00908	CcSEcCtD
Mitoxantrone—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00905	CcSEcCtD
Mitoxantrone—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00905	CcSEcCtD
Mitoxantrone—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00888	CcSEcCtD
Mitoxantrone—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00874	CcSEcCtD
Mitoxantrone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0084	CcSEcCtD
Mitoxantrone—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00838	CcSEcCtD
Mitoxantrone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00836	CcSEcCtD
Mitoxantrone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00836	CcSEcCtD
Mitoxantrone—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.0083	CcSEcCtD
Mitoxantrone—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00117	0.0147	CbGeAlD
Mitoxantrone—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0075	CcSEcCtD
Mitoxantrone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00747	CcSEcCtD
Mitoxantrone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00739	CcSEcCtD
Mitoxantrone—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00713	CcSEcCtD
Mitoxantrone—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00686	CcSEcCtD
Mitoxantrone—ABCB1—kidney—focal segmental glomerulosclerosis	0.00103	0.0129	CbGeAlD
Mitoxantrone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00675	CcSEcCtD
Mitoxantrone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00673	CcSEcCtD
Mitoxantrone—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.001	0.0126	CbGeAlD
Mitoxantrone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.00656	CcSEcCtD
Mitoxantrone—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000988	0.00651	CcSEcCtD
Mitoxantrone—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000963	0.00635	CcSEcCtD
Mitoxantrone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000956	0.0063	CcSEcCtD
Mitoxantrone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000953	0.00628	CcSEcCtD
Mitoxantrone—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.00619	CcSEcCtD
Mitoxantrone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.00619	CcSEcCtD
Mitoxantrone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.00619	CcSEcCtD
Mitoxantrone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000936	0.00617	CcSEcCtD
Mitoxantrone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00612	CcSEcCtD
Mitoxantrone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000908	0.00599	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000901	0.00594	CcSEcCtD
Mitoxantrone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000901	0.00594	CcSEcCtD
Mitoxantrone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000895	0.0059	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000882	0.00581	CcSEcCtD
Mitoxantrone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000875	0.00577	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000871	0.00574	CcSEcCtD
Mitoxantrone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000859	0.00566	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000821	0.00541	CcSEcCtD
Mitoxantrone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00533	CcSEcCtD
Mitoxantrone—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00529	CcSEcCtD
Mitoxantrone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.00528	CcSEcCtD
Mitoxantrone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.00523	CcSEcCtD
Mitoxantrone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000783	0.00516	CcSEcCtD
Mitoxantrone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.00512	CcSEcCtD
Mitoxantrone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.00508	CcSEcCtD
Mitoxantrone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.00508	CcSEcCtD
Mitoxantrone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000742	0.00489	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00486	CcSEcCtD
Mitoxantrone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000716	0.00472	CcSEcCtD
Mitoxantrone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.00469	CcSEcCtD
Mitoxantrone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.00469	CcSEcCtD
Mitoxantrone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000664	0.00438	CcSEcCtD
Mitoxantrone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000646	0.00426	CcSEcCtD
Mitoxantrone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000616	0.00406	CcSEcCtD
Mitoxantrone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000573	0.00378	CcSEcCtD
Mitoxantrone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000568	0.00374	CcSEcCtD
Mitoxantrone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000567	0.00374	CcSEcCtD
Mitoxantrone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000564	0.00372	CcSEcCtD
Mitoxantrone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000535	0.00353	CcSEcCtD
